Rocatinlimab Human Monoclonal Antibody
Rocatinlimabis a research-grade recombinant antibody targeting CD134. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
ACT35 antigen, TXGP1L, TAX transcriptionally-activated glycoprotein 1 receptor, Tumor necrosis factor receptor superfamily member 4, TNFRSF4, OX40L receptor, CD134
UniProt
P43489
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1418243-01 0.02 mg (E-Coli)
Recombinant Aromatoleum aromaticum Deoxycytidine triphosphate deaminase (dcd)
Sign In for Pricing
View Details MBS1418243-02 0.1 mg (E-Coli)
Recombinant Aromatoleum aromaticum Deoxycytidine triphosphate deaminase (dcd)
Sign In for Pricing
View Details MBS1418243-03 0.02 mg (Yeast)
Recombinant Aromatoleum aromaticum Deoxycytidine triphosphate deaminase (dcd)
Sign In for Pricing
View Details MBS1418243-04 0.1 mg (Yeast)
Recombinant Aromatoleum aromaticum Deoxycytidine triphosphate deaminase (dcd)
Sign In for Pricing
View Details